Patents by Inventor Swetha RAMAN

Swetha RAMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230042095
    Abstract: Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.
    Type: Application
    Filed: June 23, 2022
    Publication date: February 9, 2023
    Inventors: Joan SEOANE SUAREZ, Judit ANIDO FOLGUEIRA, Johan FRANSSON, Jean-Philippe JULIEN, Swetha RAMAN
  • Patent number: 11390670
    Abstract: Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: July 19, 2022
    Assignees: MEDIMMUNE LIMITED, FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGIC, FUNDACIO PRIVADA INSTITUCIO CATALANA DE RECERCA I
    Inventors: Joan Seoane Suarez, Judit Anido Folgueira, Johan Fransson, Jean-Philippe Julien, Swetha Raman
  • Publication number: 20190352389
    Abstract: Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.
    Type: Application
    Filed: December 18, 2017
    Publication date: November 21, 2019
    Inventors: Joan SEOANE SUAREZ, Judit ANIDO FOLGUEIRA, Johan FRANSSON, Jean-Philippe JULIEN, Swetha RAMAN
  • Publication number: 20180243414
    Abstract: Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.
    Type: Application
    Filed: December 18, 2017
    Publication date: August 30, 2018
    Inventors: Joan Seoane SUAREZ, Judit Anido FOLGUEIRA, Johan FRANSSON, Jean-Philippe JULIEN, Swetha RAMAN
  • Publication number: 20180169233
    Abstract: Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.
    Type: Application
    Filed: January 26, 2018
    Publication date: June 21, 2018
    Inventors: Joan Seoane SUAREZ, Judit Anido FOLGUEIRA, Johan FRANSSON, Jean-Philippe JULIEN, Swetha RAMAN